>>Cutting-Edge Science Merck's Dr. Stephen Friend and Colleagues Use Small but Powerful "DNA Chips" to Predict Which Breast Cancer Patients Need Aggressive Treatment DNA chips
By mining the riches of the human genome, Merck scientists are gaining new ideas about how some diseases are caused and how they should be treated.
Dr. Stephen Friend and his Merck affiliated colleagues in Kirkland, Wash., and West Point, Pa., are at the cutting edge of this field. Dr. Friend's group has pioneered the use of tiny "DNA chips" to study tens of thousands of genes at one time. Their work reveals how our cells function at the deepest, most fundamental, level and their findings are helping to move medicine into a new era, when a wider range of drugs will become available and genetic tests will help doctors choose the best treatment for a particular patient.<< http://www.merck.com/about/feature_story/12092002_dna_chips.html
Market Data 
Markets 
AI
